Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H37N9O2S |
InChIKeyCKAMBYUZKWQCKJ-ADSBAMQRSA-N |
CAS Registry2750570-55-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 28 Nov 2022 |